albendazole has been researched along with Environmental Hypersensitivities in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ryan, KN | 1 |
Stephenson, KB | 1 |
Trehan, I | 1 |
Shulman, RJ | 1 |
Thakwalakwa, C | 1 |
Murray, E | 1 |
Maleta, K | 1 |
Manary, MJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Randomized, Double-blind, Placebo-controlled Trial Evaluating the Impact of High-dose Zinc Therapy and Albendazole in the Treatment of Sub-clinical Environmental Enteropathy in Rural Malawian Children[NCT01440608] | 225 participants (Actual) | Interventional | 2011-10-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for albendazole and Environmental Hypersensitivities
Article | Year |
---|---|
Zinc or albendazole attenuates the progression of environmental enteropathy: a randomized controlled trial.
Topics: Albendazole; Asymptomatic Diseases; Child, Preschool; Disease Progression; Double-Blind Method; Envi | 2014 |